National Comprehensive Cancer Network (NCCN) shared on LinkedIn:
“Publication of standardized terminology for biomarker testing in JNCCN marks an important step towards building consensus and a common language around this complex and important topic.
Results of biomarker testing significantly impact patient management, prognosis, and therapy selection in oncology. Standardized biomarker testing terminology aids accurate exchange of information and will help to ensure that biomarker testing is guideline concordant so that patients receive the right treatment at the right time.”
Crystal Denlinger, Chief Executive Officer at National Comprehensive Cancer Network, shared National Comprehensive Cancer Network’s post, adding:
“Check out our new publication on National Comprehensive Cancer Network’s standardized terminology for biomarker testing.”
Other articles featuring Crystal Denlinger on OncoDaily.